Mechanisms of pancreatic β-cell apoptosis in diabetes and its therapies

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Diabetes occurs when β-cells no longer function properly or have been mostly destroyed. Pancreatic β-cell loss by apoptosis and other modes of death contributes to both autoimmune type 1 diabetes and type 2 diabetes. Programmed pancreatic β-cell death can be induced by multiple stresses in both major types of diabetes. There are also several rare forms of diabetes, including Wolcott-Rallison syndrome, Wolfram syndrome, as well as some forms of maturity onset diabetes of the young that are caused by mutations in genes that may play important roles in β-cell survival. The use of islet transplantation as a treatment for diabetes is also limited by excessive β-cell death. Mechanistic insights into the control of multiple modes of β-cell death are therefore important for the prevention and treatment of diabetes. Indeed, a substantial quantity of research has been dedicated to this area over the past decade. In this chapter, we will review the factors that influence the propensity of β-cells to die and the mechanisms of programmed cell death involved in the initiation and progression of diabetes.

Cite

CITATION STYLE

APA

Johnson, J. D., Yang, Y. H. C., & Luciani, D. S. (2015). Mechanisms of pancreatic β-cell apoptosis in diabetes and its therapies. In Islets of Langerhans, Second Edition (pp. 873–894). Springer Netherlands. https://doi.org/10.1007/978-94-007-6686-0_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free